Posts filtered by tags: BioNtech[x]


 

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 vaccine. Developed in record time in partnership with Pfizer, thanks to an existing partnership to work on immunization for the common flu, BioNTech’s mRNA inoculation is without a doubt one of the biggest medical innovations of the past century. BioNTech co-founder and CEO Uğur Şahin isn’t stopping there, of co...
Tags: TC, Technology, Hiv, Articles, Events, Tech, Ceo, Medical Research, Dropbox, Seth Rogen, Illness, Pfizer, Cloudflare, Malaria, Coinbase, Life Sciences


Oxford Scientists Are Testing a Vaccine for the Plague

The scientists who developed one of the first widely available vaccines against covid-19 are now setting their sights on a long-time microscopic foe: the plague. This week, researchers at the University of Oxford in the UK announced the start of a Phase I clinical trial testing out a potential vaccine for the plague.…Read more...
Tags: UK, Science, Medicine, Astrazeneca, Pfizer, Vaccine, University of Oxford, Vaccines, Clinical Trials, Andrew Pollard, Moderna, BioNtech, Covid 19, Covid 19 Vaccine, Health Medical Pharma, Rna Vaccines


People Who Had Allergic Reaction to First Covid-19 Shot May Tolerate the Second Just Fine, Study Suggests

People who experienced a rare allergic reaction to the mRNA covid-19 vaccines may have less to worry about than feared, new research out Monday suggests. The study, which included several U.S. medical institutions, found that people who reported a reaction following their first dose were all able to safely take the…Read more...
Tags: Science, Medicine, Pfizer, Vaccines, Allergy, Clinical Trials, Johnson Johnson, Vanderbilt University, Moderna, Anaphylaxis, BioNtech, Respiratory Diseases, Clinical Medicine, Medical Specialties, Covid 19 Vaccine, Health Medical Pharma


Early bird savings on passes to TechCrunch Disrupt 2021 end this week

Tick tock, early-stage startup fans: If you plan to attend TechCrunch Disrupt 2021 (September 21-23), time is running out to score a pass to the world’s leading conference dedicated to tech startups — for less than $100. The early bird sale ends this week, so buy your pass here before the deal expires on July 30 at 11:59 pm (PT). And if you’re part of the tech startup ecosystem — or aspire to be — why the heck wouldn’t you dive headlong into three days dedicated to the art and science required t...
Tags: TC, Business, Tech, Ceo, Economy, Companies, Pfizer, TechCrunch, Founder, Startup Company, Sahin, Michael McCarthy, Mayfield Fund, BioNtech, Verizon Media, Ursheet Parikh


Vaccine Maker BioNTech to Use MRNA Tech to Target Malaria

Pharmaceutical company BioNTech says it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
Tags: BioNtech


German Pharma-Park Marburg, Home to BioNTech, up for Sale -Sources

FRANKFURT (Reuters) - Pharma-Park Marburg, where German drugmaker BioNTech produces its COVID-19 vaccine, has been put up for sale in a potential...
Tags: Frankfurt, BioNtech, German Pharma Park Marburg Home, Reuters Pharma Park Marburg


Pfizer to start producing Covid vaccines in South Africa in 2022

Pfizer and BioNTech will start to manufacture their Covid-19 vaccine in South Africa, they announced jointly on Wednesday, in a move that could significantly increase the availability of doses across the continent next year.
Tags: News, South Africa, Stories, Pfizer, BioNtech


Pfizer-BioNTech to start producing Covid-19 vaccines in South Africa in 2022

Pfizer and BioNTech will start to manufacture their Covid-19 vaccine in South Africa, they announced jointly on Wednesday, in a move that could significantly increase the availability of doses across the continent next year.
Tags: Cnn, South Africa, Pfizer, BioNtech


COVID has become 'pandemic of the unvaccinated'; Pfizer vaccine full approval may take months: Today's updates

COVID-19 vaccine makers Pfizer and partner BioNTech said it could be months before they receive full approval for their vaccine. Live COVID news.       [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, BioNtech


'Pandemic of the unvaccinated'; Full Pfizer vaccine approval may take months: COVID-19 updates

COVID-19 vaccine makers Pfizer and its partner BioNTech said it could be months before they receive full approval for their vaccine. Live COVID news.       [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, BioNtech


FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine

Pfizer and BioNTech said Friday that the US Food and Drug Administration has granted priority review designation to their application for full approval of their Covid-19 vaccine, and an FDA official said the decision will come "soon".
Tags: News, Stories, Fda, Pfizer, US Food and Drug Administration, BioNtech


FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; agency official says approval decision expected within two months

Pfizer and BioNTech said Friday the FDA has granted priority review designation to their application for approval of their Covid-19 vaccine, and an FDA official said the decision will come within months.
Tags: Cnn, Fda, Pfizer, BioNtech, Pfizer BioNTech COVID


FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; decision on approval expected by January

Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies' application for approval of their Covid-19 vaccine. The goal date for a decision from the FDA is January 2022, the companies said.
Tags: News, Stories, Fda, Pfizer, US Food and Drug Administration, BioNtech


FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; decision on approval expected by January 2022

Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies' application for approval of their Covid-19 vaccine. The goal date for a decision from the FDA is January 2022, the companies said.
Tags: Cnn, Fda, Pfizer, US Food and Drug Administration, BioNtech


Pfizer wants to give you a booster shot—but experts say it’s too soon

Is it time to start thinking about booster shots? Pfizer seems to think so. In a private meeting with top US scientists and regulators on July 12, the firm’s representatives argued that the US should move to authorize a third shot. Last week, Pfizer and its German partner BioNTech announced that they had observed waning immunity in people who had been vaccinated and that they planned to seek emergency-use authorization for a booster dose in August. A third shot “may be beneficial to maintain the...
Tags: Israel, US, New York Times, Craig Spencer, Innovation, Who, Fda, University of Pennsylvania, Pfizer, Biden, Anthony Fauci, Centers For Disease Control And Prevention, World Health Organization WHO, Department of Health and Human Services, Ministry of Health, Swaminathan


BioNTech had planned 5 mln vaccines to Taiwan by July, diplomat says

BioNTech SE (22UAy.DE) had planned to send Taiwan five million COVID-19 vaccine doses by July under an original deal which collapsed in...
Tags: Taiwan, BioNtech


Foxconn and TSMC Strike Deal To Buy 10 Million COVID-19 Vaccines For Taiwan

Foxconn and TSMC have agreed to buy 10 million COVID-19 vaccine doses for the island of Taiwan. "The two companies will be paying up to $35 a dose of the BioNTech vaccine and donating them to the government; each company has pledged to spend $175 million," reports The Verge. From the report: BioNTech is partnered with Shanghai Fosun Pharmaceutical Co. to distribute its mRNA-based vaccine, which was co-developed with Pfizer, within China. Taiwan claims that the Chinese government blocked an attem...
Tags: Facebook, Germany, Tech, Taiwan, Beijing, Pfizer, TSMC, Foxconn, Fosun, China Taiwan, Terry Gou, BioNtech, Shanghai Fosun Pharmaceutical Co


Pfizer to Seek Approval for Booster COVID Shot, But U.S. Agencies Balk at Timing

By Ernie Mundell and Robin Foster HealthDay ReportersFRIDAY, July 9, 2021 (HealthDay News) -- Pfizer and its partner BioNTech announced Thursday...
Tags: Pfizer, BioNtech, Robin Foster, Ernie Mundell, HealthDay News Pfizer, U S Agencies Balk


Pfizer's COVID-19 booster shot strongly extends protection but CDC cautions 3rd dose not yet needed

Pfizer and BioNTech say their COVID booster provides extended protection and are updating the vaccine to target the highly contagious Delta variant.       [Author: USA TODAY]
Tags: Usa, News, Cdc, Pfizer, Usa Today, BioNtech, COVID


Pfizer COVID-19 booster shot extends strong protection, company says, vaccine being updated to target Delta variant

Pfizer and BioNTech say their COVID booster provides extended protection and are updating the vaccine to target the highly contagious Delta variant.       [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, BioNtech


How well COVID-19 vaccines work against the Delta variant, according to the best available data

A nurse at the Royal Cornwall Hospital prepares to administer a COVID-19 vaccine in Truro, United Kingdom. Hugh Hastings/Getty Images The Delta variant is the most common cause of new COVID-19 infections in the US, the UK, and elsewhere. Delta has mutations that can help it avoid the immune response. Four studies suggest vaccines from Pfizer, Moderna, and AstraZeneca work against Delta, to varying degrees. See more stories on Insider's business page. The highly-infectious Delta coronav...
Tags: Health, UK, Science, Scotland, India, Israel, US, Trends, Healthcare, Delta, Astrazeneca, Pfizer, Lancet, Variant, Stephen Evans, The World Health Organization


How well COVID-19 vaccines protect against the Delta variant, according to the best available data

A nurse at the Royal Cornwall Hospital prepares to administer a COVID-19 vaccine in Truro, United Kingdom. Hugh Hastings/Getty Images The Delta variant is the most common cause of new COVID-19 infections in the US, the UK, and elsewhere. Delta has mutations that can help it avoid the immune response. Four studies suggest vaccines from Pfizer, Moderna, and AstraZeneca work against Delta, to varying degrees. See more stories on Insider's business page. The highly-infectious Delta coronav...
Tags: Health, UK, Science, Scotland, India, Israel, US, Trends, Healthcare, Delta, Astrazeneca, Pfizer, Lancet, Variant, Stephen Evans, The World Health Organization


COVID Vaccines To Reach Poorest Countries in 2023 -- Despite Recent Pledges

Most people in the poorest countries will need to wait another two years before they are vaccinated against COVID-19, researchers have told Nature. From a report: Around 11 billion doses are needed to fully vaccinate 70% of the world's population against COVID-19. As of 4 July, 3.2 billion doses had been administered. At the current vaccination rate, this will increase to around six billion doses by the end of the year, researchers from the International Monetary Fund, based in Washington DC, pr...
Tags: Japan, New York City, US, Tech, Joe Biden, Washington Dc, United Kingdom, International Monetary Fund, Pfizer, France Germany, Mainz Germany, Cornwall UK, BioNtech, COVID


Covid-19 Vaccines Make Breakthrough Infections Shorter, Less Contagious: CDC Study

New research published this week is the latest to indicate that vaccinated people have much less to fear from covid-19. The study found that even in the rare cases when people given mRNA vaccines developed infections, they tended to experience shorter illness and produce less of the virus than unvaccinated people—both…Read more...
Tags: Health, Science, Medicine, Cdc, Virus, Pfizer, Vaccine, Virology, Clinical Trials, Johnson Johnson, Moderna, BioNtech, Medical Specialties, Zoonoses, Covid 19 Vaccine, Health Medical Pharma


CDC Stands by Masking Guidelines, Says Vaccinated Americans Are Safe From Delta Variant

The head of the Centers for Disease Control and Prevention, Rochelle Walensky, is trying to assuage vaccinated people’s fears about the Delta variant of the coronavirus. This morning, Walensky said that vaccinated people should remain protected from Delta and that they still didn’t need to wear masks in most…Read more...
Tags: Science, Medicine, Cdc, Delta, Vaccination, Astrazeneca, Health Care, Pfizer, Vaccine, Centers For Disease Control And Prevention, Biotechnology, Johnson Johnson, Moderna, BioNtech, Rochelle Walensky, Walensky


Covid live news: UK records 26,068 cases, most since January; pandemic end is ‘distant future’ in Latin America

UK records 14 further deaths as cases surge; new infections declining in north America but warning for Latin America as vaccinations lagAustralia: Queensland says Pfizer vaccine supply will run out in daysNorth Korea outbreak fears after Kim Jong-un warns of ‘huge crisis’Sage scientist fears England could repeat ‘mistakes of last summer’Brazil suspends Covaxin contract after accusations of irregularitiesLA recommends indoor masks regardless of vaccination status 6.25pm BST Germany plans to b...
Tags: UK, England, Germany, America, European Union, World news, Queensland, Brazil, Vaccines and immunisation, Pfizer, Latin America, Reuters, Kim Jong, BioNtech, Coronavirus, Robert Dingwall


How Worried Should Vaccinated People Be About the Delta Variant?

The arrival of the Delta variant—the recently emerged strain of the coronavirus thought to be the most transmissible yet—in the U.S. is understandably unnerving scientists and the public alike. But how worried should you exactly be about Delta, especially if you’re fully vaccinated already?Read more...
Tags: Science, Medicine, Delta, Vaccination, Astrazeneca, Pfizer, Vaccine, Vaccines, Biotechnology, Clinical Trials, Johnson Johnson, B, BioNtech, Medical Specialties, Health Medical Pharma, Varicella Vaccine


How much protection you get from one dose of the Pfizer, AstraZeneca, and Moderna vaccines, according to the best available data

Pfizer's COVID-19 vaccine. Getty Millions of people worldwide have had one shot of two-dose COVID-19 vaccines. Pfizer and Moderna's vaccines are likely 80% effective against symptomatic COVID-19 after one dose. A single AstraZeneca shot is probably at least 70% effective at preventing symptomatic COVID-19. See more stories on Insider's business page. More than 179 million Americans and more than 44 million Britons have received their first dose of a two-shot COVID-19 vaccine.Th...
Tags: Health, UK, England, Science, India, Israel, US, Trends, Joe Biden, Data, South Africa, Healthcare, Food And Drug Administration, Brazil, Astrazeneca, Evans


Some experts who had Johnson & Johnson's single-dose vaccine are now getting extra shots of Pfizer or Moderna to try to protect against the Delta variant

A pharmacist at the Hartford Hospital in Hartford, Connecticut, fills a syringe with the Johnson & Johnson COVID-19 vaccine. Joseph Prezioso/Getty Images Some experts who got Johnson & Johnson's one-dose vaccine are topping it up with a dose of Pfizer or Moderna. They did it for extra protection against the fast-spreading Delta coronavirus variant, they said. The FDA and CDC don't recommend getting an extra shot, after a J&J vaccine or otherwise. See more stories on Insider's b...
Tags: Health, UK, Science, News, Cdc, US, Trends, Joe Biden, Healthcare, Delta, Astrazeneca, Fda, Pfizer, Vaccine, Johnson, Anthony Fauci


Hopes Are High for the mRNA Technology that Is Leading Us Out of the Pandemic

The vaccine success stories at BioNTech and Moderna may only be the beginning. Doctors and researchers want to use the revolutionary mRNA technology to fight the world's worst scourges: from cancer to dementia.
Tags: Moderna, BioNtech